Defense Health Program Department of Defense Spinal Cord Injury Research Program Funding Opportunities for Fiscal Year 2019 (FY19)

Posted on by

The FY19 Defense Appropriation provides $30 million (M) to the Department of Defense Spinal Cord Injury Research Program (SCIRP) to support innovative, high-impact spinal cord injury research. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency J9, Research and Development Directorate, manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcements/Funding Opportunities is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

FY19 SCIRP Program Announcements and General Application Instructions for the following award mechanisms are posted on the Grants.gov website.

For FY19, SCIRP encourages applications that address the critical needs of SCI research and patient care in one or more of the following FY19 Focus Areas:

  • Neuroprotection
  • Biomarkers
  • Bladder dysfunction,  bowel dysfunction and neuropathic pain
  • Psychosocial issues relevant to SCI in  individuals with SCI or their caregivers
  • Rehabilitation and regeneration

Clinical Trial Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

  • Fund Phase 0, I, or II clinical trials with the potential to have a major impact on treatment or management of spinal cord injury (SCI) and its consequences.
  • Applications must include at least two SCI consumer advocates as members of the research team.
  • Preliminary data relevant to the proposed trial required for all clinical trial applications.
  • Pre-application required; application submission is by invitation only.
  • The maximum allowable funding for the entire period of performance is of $3, 000,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institutions’ negotiated rate agreement.
  • The maximum period of performance is 4 years

Investigator-Initiated Research Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

  • Fund SCI-related research that has the potential to make an important contribution to SCI research and/or patient care, and/or quality of life.
  • Preliminary data required.
  • Clinical trials not allowed.
  • Pre-application required; application submission by invitation only.
  • The maximum allowable funding for the entire period of performance is $500,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years.

Translational Research Award – Preproposal due May 29, 2019

Independent investigators at all academic levels (or equivalent)

  • Fund studies that accelerate the movement of promising ideas in SCI research into clinical applications.
  • Applications must include at least one SCI consumer advocate as a member of the research team.
  • Preliminary data required
  • The SCIRP TRA may include a pilot clinical trial where limited clinical testing of a novel intervention or device is necessary to inform the next step in the continuum of translational research.
  • Pre-application required; application submission by invitation only.
  • The maximum allowable funding for the entire period of performance is $1,250,000 for direct costs.
  • Indirect costs may be proposed in accordance with the institution’s negotiated rate agreement.
  • The maximum period of performance is 3 years

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website.  The application package containing the required forms for each award mechanism is also on Grants.gov.  A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420. 

For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org.  For more information about the SCIRP or other CDMRP-administered programs, please visit the CDMRP website (https://cdmrp.army.mil).

Point of Contact:

CDMRP Help Desk

301-682-5507
help@eBrap.org